Pharmacological descriptors related to the binding of Gp120 to CD4 corresponding to 60 representative HIV-1 strains

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 28, Issue 5, 2013, Pages 1015-1025

  Calborean, Octavian ^a   Mernea, Maria ^a   Avram, Speranta ^a   Mihailescu, Dan Florin ^a  

^a UNIVERSITY OF BUCHAREST   (Romania)

Author keywords

CD4 binding site; Gp120; HIV 1 strains; Homology modelling; Pharmacological descriptors

Indexed keywords

ALANINE; ASPARAGINE; CD4 ANTIGEN; GLYCOPROTEIN GP 120; THREONINE;

ANTIGEN BINDING; ARTICLE; BINDING SITE; CORRELATIONAL STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANTIGENS, CD4; BINDING SITES; HIV ENVELOPE PROTEIN GP120; HIV-1; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84884241793     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2012.705836     Document Type: Article

References (24)

1. Hartley O, Klasse PJ, Sattentau QJ, Moore JP. V3: HIV's switchhitter. AIDS Res Hum Retroviruses 2005;21:171-189.
2. Chen B, Vogan EM, Gong H, Skehel JJ, Wiley DC, Harrison SC. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 2005;433:834-841.
3. Walker LM, Burton DR. Rational antibody-based HIV-1 vaccine design: Current approaches and future directions. Curr Opin Immunol 2010;22:358-366.
4. Stamatatos L, Morris L, Burton DR, Mascola Jr. Neutralizing antibodies generated during natural HIV-1 infection: Good news for an HIV-1 vaccine? Nat Med 2009;15:866-870.
5. Lin G, Nara PL. Designing immunogens to elicit broadly neutralizing antibodies to the HIV-1 envelope glycoprotein. Curr HIV Res 2007;5:514-541.
6. Corti D, Langedijk JP, Hinz A, Seaman MS, Vanzetta F, Fernandez-Rodriguez BM et al. Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals. PLoS ONE 2010;5:e8805.
7. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998;393:648-659.
8. Brown BK, Darden JM, Tovanabutra S, Oblander T, Frost J, Sanders- Buell E et al. Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01-AE, and CRF02-AG, for the development and assessment of candidate vaccines. J Virol 2005;79:6089-6101.
9. Leonard JT, Roy K. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors. Eur J Med Chem 2008;43:81-92.
10. Richards FM. The interpretation of protein structures: Total volume, group volume distributions and packing density. J Mol Biol 1974;82:1-14.
11. Richmond TJ. Solvent accessible surface area and excluded volume in proteins. Analytical equations for overlapping spheres and implications for the hydrophobic effect. J Mol Biol 1984;178:63-89.
12. Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res 2012;40:D71-D75.
13. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW. GenBank. Nucleic Acids Res 2011;39:D32-D37.
14. Huang CC, Tang M, Zhang MY, Majeed S, Montabana E, Stanfield RL et al. Structure of a V3-containing HIV-1 gp120 core. Science 2005;310:1025-1028.
15. Guilhaudis L, Jacobs A, Caffrey M. Solution structure of the HIV gp120 C5 domain. Eur J Biochem 2002;269:4860-4867.
16. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ. Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 2009;25:1189-1191.
17. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993;234:779-815.
18. Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, Xiang SH et al. Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 2007;445:732-737.
19. Xiang SH, Kwong PD, Gupta R, Rizzuto CD, Casper DJ, Wyatt R et al. Mutagenic stabilization and/or disruption of a CD4- bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein. J Virol 2002;76:9888-9899.
20. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M. CHARMM: A Program for macromolecular energy, minimization, and dynamics calculations. J Comp Chem 1983;4:187-217.
21. Humphrey W, Dalke A, Schulten K. VMD: Visual molecular dynamics. J Mol Graph 1996;14:33-8, 27.
22. Im W, Beglov D, Roux B. Continuum solvation model: Computation of electrostatic forces from numerical solutions to the Poisson-Boltzmann equation. Comput Phys Comm 1998;111:59-75.
23. Mackerell AD Jr, Feig M, Brooks CL 3rd. Extending the treatment of backbone energetics in protein force fields: Limitations of gasphase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations. J Comput Chem 2004;25:1400-1415.
24. Levy Y, Onuchic JN. Water and proteins: A love-hate relationship. Proc Natl Acad Sci USA 2004;101:3325-3326.